Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease × Prednisone × Clear all

Phase

Status

Completed 3 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 36 Lymphoma, Large B-Cell, Diffuse 16 Lymphoma 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Neoplasms 6 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Leukemia 6 Burkitt Lymphoma 6 Lymphoma, B-Cell 5 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Lymphoma, T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Pain 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Lymphatic Diseases 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumours 1 Sezary Syndrome 1

Interventions

obinutuzumab 1 ioflupane 1 idelalisib 1 daratumumab 1 alovudine 1 Vindesine 1 Vincristine 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ga(III)-DOTATOC 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡